Clinically important yeasts


Update content

Title Clinically important yeasts
Period 01 / 2002 - 12 / 2006
Status Completed
Research number OND1310329
Data Supplier Website Centraalbureau voor Schimmelcultures


In this project the biodiversity and detection of clinical important yeasts is investigated. Emphasis is on Malassezia spp., Trichosporon spp., Cryptococcus spp. (incl. C. neoformans), and Candida species. Next to biodiversity and population studies, the development of rapid and reliable identification tools is also important. The biodiversity of these yeasts is being studied using rDNA and other sequences, as well as DNA fingerprint approaches such as amplified fragment length polymorphism (AFLP). The genomes of several of these yeasts have been sequenced (e.g. Candida spp., Cryptococcus neoformans), which will allow the development of rapid and reliable molecular identification techniques.

Related organisations

Other involved organisations

Procter &Gamble, Cincinnati (USA): T. Dawson
Mediprobe, London (Canada): A. Gupta and R. Batra
CDC, Atlanta GA (USA): A. Borst
Universiteit Gent (Belgium): T. Bauters and M. Vaneechoutte
Hadassah Hospital, Jerusalem (Israel): I. Polacheck

Related people

Project leader Dr. T. Boekhout


D21400 Genetics
D22100 Microbiology

Go to page top
Go back to contents
Go back to site navigation